News

News

Hikma launches Labetalol Hydrochloride Injection, USP in prefilled syringe

News

News

Hikma launches Icosapent Ethyl Capsules, 0.5g, in the US

News

News

Hikma launches Cefazolin for Injection, USP, in the US

Watch Said Darwazah, Executive Chairman and Chief Executive Officer discuss our 2022 financial results

Friday 28 April 2023, 11.00 AM GMT, Sofitel London St James, 6 Waterloo Place, London SW1Y 4AN

Listen to our 2022 results Q&A call with our leadership team

#OwnYourCareer@Hikma

Meet Kimberly Lembo, Associate Director, Contract Lifecycle Management and Systems, US and discover why she loves working at Hikma!

#OwnYourCareer@Hikma

Meet Carl Mullner, Manager, Offer Development, US and discover why he loves working at Hikma!

Latest blogpost

Latest blogpost

Read the latest blog post by Lana Ghanem, Managing Director, Hikma Ventures and Vice President, Digital Health Investments & Partnerships - Investing in the disruptive future of the pharmaceutical industry.

Latest blogpost

Latest blogpost

Read the latest blog post by Riad Mishlawi, President, Hikma Injectables on Hikma’s world class Injectables capabilities - bringing access to critical medicines.

Careers

Careers

Join us in helping to put better health within reach for millions of people

Find out more

Find out more

Our 2021 Sustainability Report

Find out more

Find out more

Our 2022 Annual Report